Search results for: 'mania and acquisition deal of 2026'
- Did you mean
- manag and acquisition deaf of 2004
- Related search terms
- acquisition texas and agreements in pharma
- deal+on+demand
- deals+on+demand
- acquisition test and agreements in pharma
- deal chapter specif 2017
-
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026March 2026$4,995.00The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report offers in-depth insights and exclusive access to clinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Current Partnering Knowledge CenterApril 2026$14,995.00The Leading Partnering Intelligence Platform for Pharma, Biotech and Diagnostic Dealmakers
Learn More -
Central Nervous System (CNS) Collaboration and Licensing Deals 2020-2026April 2026$3,995.00Central Nervous System (CNS) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2020 to 2026
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology Deals 2015 to 2026March 2026$4,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2026 | 11+ years of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Antibody Collaboration and Licensing Deals 2019-2026April 2026$3,995.00Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Generic Pharmaceutical Partnering Terms and Agreements 2010-2026January 2026$3,995.00Global Generic Pharmaceutical Partnering Terms and Agreements 2010 to 2026 report provides a detailed understanding and analysis of how and why companies enter generic pharmaceutical partnering deals.
Learn More -
Academic and Non-Profit Partnering Terms and Agreements 2021-2026March 2026$4,995.00Academic and Non-Profit Partnering Terms and Agreements 2021-2026 provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals.
Learn More -
Infectious Vaccine Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Vaccine Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Diagnostic Collaboration and Licensing Deals 2020-2025May 2025$4,995.00Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2020 to 2025
Learn More
- Category CP Reports Store Remove This Item
